vs
IDEAYA Biosciences, Inc.（IDYA）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是IDEAYA Biosciences, Inc.的2.0倍（$411.1M vs $207.8M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 48.4%，领先9.0%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $25.1M）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
IDYA vs PATH — 直观对比
营收规模更大
PATH
是对方的2.0倍
$207.8M
净利率更高
IDYA
高出9.0%
48.4%
自由现金流更多
IDYA
多$117.1M
$25.1M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $411.1M |
| 净利润 | $119.2M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | 52.2% | 3.2% |
| 净利率 | 57.4% | 48.4% |
| 营收同比 | — | 15.9% |
| 净利润同比 | 330.1% | 1966.2% |
| 每股收益（稀释后） | $1.33 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYAPATH
| Q4 25 | — | $411.1M | ||
| Q3 25 | $207.8M | $361.7M | ||
| Q2 25 | — | $356.6M | ||
| Q1 25 | — | $423.6M | ||
| Q4 24 | — | $354.7M | ||
| Q3 24 | $0 | $316.3M | ||
| Q2 24 | $0 | $335.1M | ||
| Q1 24 | $0 | $405.3M |
净利润IDYAPATH
| Q4 25 | — | $198.8M | ||
| Q3 25 | $119.2M | $1.6M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $51.8M | ||
| Q4 24 | — | $-10.7M | ||
| Q3 24 | $-51.8M | $-86.1M | ||
| Q2 24 | $-52.8M | $-28.7M | ||
| Q1 24 | $-39.6M | $33.9M |
毛利率IDYAPATH
| Q4 25 | — | 83.3% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 83.5% | ||
| Q1 24 | — | 86.8% |
营业利润率IDYAPATH
| Q4 25 | — | 3.2% | ||
| Q3 25 | 52.2% | -5.6% | ||
| Q2 25 | — | -4.6% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | -12.2% | ||
| Q3 24 | — | -32.7% | ||
| Q2 24 | — | -14.8% | ||
| Q1 24 | — | 3.7% |
净利率IDYAPATH
| Q4 25 | — | 48.4% | ||
| Q3 25 | 57.4% | 0.4% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | -3.0% | ||
| Q3 24 | — | -27.2% | ||
| Q2 24 | — | -8.6% | ||
| Q1 24 | — | 8.4% |
每股收益（稀释后）IDYAPATH
| Q4 25 | — | $0.37 | ||
| Q3 25 | $1.33 | $0.00 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.60 | $-0.15 | ||
| Q2 24 | $-0.68 | $-0.05 | ||
| Q1 24 | $-0.53 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $1.9B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDYAPATH
| Q4 25 | — | $1.4B | ||
| Q3 25 | $786.9M | $1.4B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $920.0M | $1.7B | ||
| Q2 24 | $701.7M | $1.9B | ||
| Q1 24 | $698.8M | $1.9B |
股东权益IDYAPATH
| Q4 25 | — | $1.9B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $931.7M | $2.0B | ||
| Q1 24 | $935.3M | $2.0B |
总资产IDYAPATH
| Q4 25 | — | $2.9B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $973.7M | $2.8B | ||
| Q1 24 | $961.5M | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | $25.1M |
| 自由现金流率自由现金流/营收 | 68.4% | 6.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.8% |
| 现金转化率经营现金流/净利润 | 1.19× | 0.14× |
| 过去12个月自由现金流最近4个季度 | $13.5M | — |
8季度趋势，按日历期对齐
经营现金流IDYAPATH
| Q4 25 | — | $28.3M | ||
| Q3 25 | $142.2M | $41.6M | ||
| Q2 25 | — | $119.0M | ||
| Q1 25 | — | $146.1M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | $-49.2M | $46.4M | ||
| Q2 24 | $-32.9M | $100.0M | ||
| Q1 24 | $-43.8M | $145.6M |
自由现金流IDYAPATH
| Q4 25 | — | $25.1M | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | $106.2M | ||
| Q1 25 | — | $138.7M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | $-49.7M | $45.0M | ||
| Q2 24 | $-33.9M | $98.8M | ||
| Q1 24 | $-45.1M | $141.8M |
自由现金流率IDYAPATH
| Q4 25 | — | 6.1% | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | 29.8% | ||
| Q1 25 | — | 32.7% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 29.5% | ||
| Q1 24 | — | 35.0% |
资本支出强度IDYAPATH
| Q4 25 | — | 0.8% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.9% |
现金转化率IDYAPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | 1.19× | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDYA
暂无分部数据
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
